Donald Trump speaking with supporters at a campaign rally at Veterans Memorial Coliseum at the Arizona State Fairgrounds in Phoenix, Arizona. Please attribute to Gage Skidmore if used elsewhere.

Analysts now put the odds of Trump’s promised $2,000 tariff-dividend checks near zero after the Supreme Court struck the tariffs.

President Donald Trump spent much of 2025 and early 2026 promising that tariff revenue would fund a $2,000 “dividend” check for American households. Retirees on fixed incomes, many of whom watch every federal payment closely, were among the most attentive to that promise. Financial analysts now say the payment is close to impossible, and the…

Read More
Image Credit: Department of Defense - Public domain/Wiki Commons

Consumers who bought generic drugs between 2009 and 2019 have to register before the money is split.

Consumers who filled a generic prescription made by one of five drug companies between 2009 and 2019 need to register before any settlement money moves, and that step is not the same as filing a claim. The distinction matters because a $29.6 million settlement with generic drug maker Glenmark cleared preliminary court approval on August…

Read More
A portable power bank battery charger

A recalled portable charger has been tied to a fire that killed a 75-year-old woman, and owners can get a free replacement.

A wireless portable power bank sold under the Casely brand remains under an active federal recall after being linked to a fire that killed a 75-year-old New Jersey woman, according to the U.S. Consumer Product Safety Commission. About 429,200 of the pocket-sized chargers are covered, and the remedy the agency lists is a free replacement,…

Read More
person sitting while using laptop computer and green stethoscope near

State regulators in several states are fighting double-digit health premium increases proposed for 2027.

Health insurers asking for double-digit rate increases on 2027 plans are running into organized resistance from state officials in at least three states. Connecticut, Rhode Island and Massachusetts have each pushed back this year on requests from major carriers, using the leverage state law gives regulators to question, reject, or renegotiate proposed premiums before they…

Read More
Image by Freepik

Forty-eight states won $29.6 million from a generic-drug maker accused of fixing prices, and buyers can register for a share.

A coalition of 48 states and territories has locked in a $29.6 million settlement with generic drug manufacturer Glenmark Pharmaceuticals over accusations that the company conspired with rivals to inflate prices on dozens of generic prescriptions. A federal court in Connecticut granted preliminary approval to the deal on August 7, 2026, moving the case a…

Read More